ETF Home ETF List Shorted Stocks Home About

ETF Holdings Breakdown of RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

RPRX institutional holdings

The adjusted close for RPRX on 2026-01-14 was 40.21

The following institutional investment holdings of RPRX have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2026-01-14 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 2,259USD 90,834 40.21  
2026-01-14 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 3,893USD 156,538 -0.4% 40.21  
2026-01-14 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 9,791USD 393,696 -0.4% 40.21  
2026-01-14 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 126,758USD 5,096,939 40.21  
2026-01-14 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 682,340USD 27,436,891 40.21  
2026-01-14 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 7,522USD 302,460 40.21  
2026-01-14 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 42,743USD 1,718,696 -0.4% 40.21  
2026-01-14 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 6,796USD 273,267 40.21  
2026-01-14 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 2,799USD 83,638 29.88 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 40.21 not 29.88. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B42YS929 incorrectly reporting value of holding as USD actually is reported in GBP
2026-01-14 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 30,831USD 1,063,220 34.49 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 40.21 not 34.49. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B441G979 incorrectly reporting value of holding as USD actually is reported in EUR
2026-01-14 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 682,340USD 27,436,891 40.21  
2026-01-14 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 23,697USD 952,856 40.21  
2026-01-14 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 25,221USD 1,014,136 -0.4% 40.21  
2026-01-14 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 168,975USD 6,794,485 40.21  
2026-01-14 IE00BD1F4N50 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Acc) GBP) 19,547USD 785,985 40.21  
2026-01-14 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 682,340USD 27,436,891 40.21  
2026-01-14 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 291,613USD 11,725,759 40.21  
2026-01-14 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 168,975 0.1%USD 6,794,485 -0.3% 40.21  
2026-01-14 IE00BFF5RZ82 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)) 19,547USD 785,985 40.21  
2026-01-14 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 126,758 -0.5%USD 5,096,939 -0.4% 40.21  
2026-01-14 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 37,584USD 1,511,253 40.21  
2026-01-14 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 37,584 0.6%USD 1,511,253 0.2% 40.21  
2026-01-14 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 158,183USD 6,360,538 40.21  
2026-01-14 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 166,297USD 6,686,802 40.21  
2026-01-14 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 4,478USD 180,060 40.21  
2026-01-14 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 166,297USD 6,686,802 -0.4% 40.21  
2026-01-14 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 59,375 0.1%USD 2,387,469 -0.3% 40.21  
2026-01-14 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 9,791USD 393,696 40.21  
2026-01-14 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 682,340USD 27,436,891 40.21  
2026-01-14 IE00BKM4H312 (iShares MSCI USA Dividend IQ UCITS) 43,341USD 1,742,742 -0.4% 40.21  
2026-01-14 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 8,676USD 348,862 40.21  
2026-01-14 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 108,604USD 4,366,967 -0.4% 40.21  
2026-01-14 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 11,470USD 461,209 -0.4% 40.21  
2026-01-14 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 204,540USD 8,224,553 -0.4% 40.21  
2026-01-14 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 204,540USD 8,224,553 -0.4% 40.21  
2026-01-14 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 11,470USD 461,209 -0.4% 40.21  
2026-01-14 IE00BP3QZ825 (iShares Edge MSCI World Momentum Factor UCITS ETF) 67,293USD 2,705,852 40.21  
2026-01-14 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 158,183USD 6,360,538 40.21  
2026-01-14 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 13,207USD 531,053 -0.4% 40.21  
2026-01-14 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 108,604USD 4,366,967 -0.4% 40.21  
2026-01-14 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 204,540USD 8,224,553 40.21  
2026-01-14 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 291,613 0.5%USD 11,725,759 0.1% 40.21  
2026-01-14 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 21,784USD 875,935 -0.4% 40.21  
2026-01-14 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 4,478USD 180,060 -0.4% 40.21  
2026-01-14 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 21,784USD 875,935 -0.4% 40.21  
2026-01-14 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 108,604USD 4,366,967 40.21  
2026-01-14 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 108,604USD 4,366,967 40.21  
2026-01-13 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 88,350 0.5%USD 3,565,806 0.8% 40.36 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 40.21 not 40.36. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2026-01-13 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 127,200USD 5,133,792 0.2% 40.36 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 40.21 not 40.36. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2026-01-07 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 87,890 0.8%USD 3,637,767 6.8% 41.39 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 40.21 not 41.39. May be due to incorrect reporting of currency . Could be EUR or USD instead 
Total =6,451,449 USD 259,343,401
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.
(RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52
Stock Traders Buy High Volume of Royalty Pharma Put Options (NASDAQ:RPRX)
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) saw some unusual options trading on Thursday. Stock traders purchased 4,237 put options on the stock. This is an increase of 344% compared to the typical volume of 954 put options. Institutional Trading of Royalty Pharma Institutional investors and hedge funds have recently modified their holdings of […] - 2025-03-28 05:07:01

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Copyright Market Footprint Ltd. Privacy Policy